Company news
Relmada Therapeutics, Inc. news in 2019
Relmada Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
December 8, 2019
Relmada Therapeutics Announces Pricing of Public Offering of Common Stock
December 2, 2019
Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15
October 13, 2019
Relmada Therapeutics Announces Commencement of Trading on The NASDAQ Capital Market
October 9, 2019
Decks in 2019
- Investor Presentation (December 2019)
Investor deck · 26 slides · Dec 3, 2019
- Technical Presentation (October 2019)
Technical · 8 slides · Oct 21, 2019